Steven Hardy, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Vertex Pharmaceuticals
    Topic:
    Promoting effective dialogues about curative therapies for sickle cell disease
    Date added:
    04/07/2025
    Date updated:
    04/07/2025
    Relationship end date:
    10/30/2024
Return to Solid Tumor, NeuroOnc, Late Effects 10/9/2025